Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: January 2017

1/31/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (December 2016)

In 2016, Russian manufacturers produced and dispatched 314.5 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 23.7% higher than that of 2015 and is way above the average performance. In physical terms, the dispatch volumes have risen by 7.6% over the year, with 4.3 bln units of pharmaceuticals.

1/24/2017 Database Update: Veterinary Drug and Feed Supplement Import to Russia (December 2016)

In 2016, Russia imported 22 bln RUB worth of veterinary drugs (free circulation prices) and 9.3 bln RUB worth of feed supplements and premixes. Over the year, the veterinary drug import has risen by 12.7% in monetary terms, while the feed supplement import has risen only by 4.4%.

1/19/2017 Database Update: Pharmaceutical Drug Import to Russia (December 2016)

In 2016, Russia imported 493.1 bln RUB worth of ready-made pharmaceuticals (free circulation prices). The in-bulk imports amounted to 100.2 bln RUB. In monetary terms, the imports of ready-made products and in-bulk products have increased by 8.1% and 17.1%, respectively. In physical terms, the import of ready-made products has increased by 0.5%, while the in-bulk import has a bigger rise.